News | Image Guided Radiation Therapy (IGRT) | June 14, 2018

Next-generation cancer therapy enables delivery of higher, potentially more effective radiation dose regimens

Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac

June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis has begun treating patients with Viewray's second-generation magnetic resonance (MR) image-guided radiotherapy system, the MRIdian Linac. Siteman is the first U.S. cancer center to offer cancer therapy with both MRIdian and MRIdian Linac.

Washington University physicians and researchers at Siteman played an integral role in the development, testing and clinical introduction of MRIdian in 2012. The first cancer patients worldwide to receive MR-guided radiation therapy were treated at Siteman.

Unlike conventional radiotherapy, MRIdian Linac technology uses high-definition MR soft-tissue imaging to visualize and track the detailed contours of the tumor and adjacent healthy tissues. The enhanced visibility allows clinicians to quickly and dynamically adjust the prescribed radiation dose distribution when the tumor moves during the course of treatment. The combined capabilities provide clinicians with the tools to improve targeting precision and thus deliver higher and potentially more effective radiation doses, while simultaneously minimizing incidental radiation exposure to surrounding organs.

"We know that tumors and their surrounding anatomy naturally change position from day to day — even during treatment — making it vitally important that we see where the radiation dose is being delivered in real-time," said Jeff Bradley, M.D., the S. Lee Kling Professor of Radiation Oncology at Washington University. "The clarity and detail afforded by MRI combined with this new technology allows us to target tumors with a high level of accuracy regardless of changes or motion, further enabling us to expand our treatment options."

"As an institution actively involved in advancing MR image-guided therapy since the very beginning, we are excited to remain at the forefront with the addition of this latest innovation," said Jeff Michalski, M.D., professor and vice chair of the Department of Radiation Oncology at Washington University.

For more information: www.viewray.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now